ArticleInfluenza and other respiratory viruses2023

Comparison of the risk of hospitalisation among BA.1 and BA.2 COVID-19 cases treated with sotrovimab in the community in England.

Katie Harman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.